Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Cancer of Prostate

ng-nitroarginine methyl ester has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellone, M; Capuano, G; Freschi, M; Generoso, L; Grioni, M; Jachetti, E; Ricupito, A; Rigamonti, N1
Abraham, NG; Acquaviva, R; Barbagallo, I; Cardile, V; Di Giacomo, C; Santangelo, R; Sorrenti, V; Vanella, L1

Other Studies

2 other study(ies) available for ng-nitroarginine methyl ester and Cancer of Prostate

ArticleYear
Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Mar-01, Volume: 17, Issue:5

    Topics: Adenocarcinoma; Animals; Arginine; CD11b Antigen; Cell Proliferation; Disease Progression; Immune Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelopoiesis; NG-Nitroarginine Methyl Ester; Piperazines; Prostatic Neoplasms; Purines; Sildenafil Citrate; Sulfones; T-Lymphocytes; Tumor Cells, Cultured

2011
The DDAH/NOS pathway in human prostatic cancer cell lines: antiangiogenic effect of L-NAME.
    International journal of oncology, 2011, Volume: 39, Issue:5

    Topics: Amidohydrolases; Angiogenesis Inhibitors; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; Humans; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Prostatic Neoplasms; Vascular Endothelial Growth Factor A

2011